相似文献
1
Studies on the effect of probenecid (benemid) in gout.
Ann Rheum Dis. 1954 Jun;13(2):120-30. doi: 10.1136/ard.13.2.120.
2
Gout: six-year follow-up on probenecid (benemid) therapy.
Arthritis Rheum. 1959 Jun;2(3):193-202. doi: 10.1002/1529-0131(195906)2:3<193::aid-art1780020302>3.0.co;2-8.
3
Probenecid (benemid); its uses and side-effects in 2,502 patients.
AMA Arch Intern Med. 1955 Jan;95(1):83-92. doi: 10.1001/archinte.1955.00250070099012.
4
[Treatment of gout with phenylbutazone associated with benemid].
Acta Physiother Rheumatol Belg. 1953 May-Jun;8(3):95-7.
5
[Gout, joint diseases; trial therapy with benemid].
Alger Medicale. 1955 Aug;59(8):521-2.
6
[New American anti-gout agent; benemid].
Rhumatologie. 1952 Nov-Dec(6):228-32.
7
[Therapy of chronic gout with benemid and cortisone].
Klin Wochenschr. 1954 Feb 1;32(5-6):136-7. doi: 10.1007/BF01469324.
8
Clinical and metabolic effects of benemid.
Ann Rheum Dis. 1952 Dec;11(4):294-5.
9
Benemid.
Proc R Soc Med. 1956 Aug;49(8):591-4.
10
Effect of benemid in gouty arthritis.
Ann Rheum Dis. 1951 Dec;10(4):493-4.
引用本文的文献
1
Detailed Studies on the Methoxylation and Subsequent Dealkylation of -Diethylbenzenesulfonamide Using a Tailor-Made Electrosynthetic Reactor.
Molecules. 2024 Nov 21;29(23):5496. doi: 10.3390/molecules29235496.
2
The substrate and inhibitor binding mechanism of polyspecific transporter OAT1 revealed by high-resolution cryo-EM.
Nat Struct Mol Biol. 2023 Nov;30(11):1794-1805. doi: 10.1038/s41594-023-01123-3. Epub 2023 Oct 16.
3
A Sulfoxide Reagent for One-Pot, Three-Component Syntheses of Sulfoxides and Sulfinamides.
Angew Chem Int Ed Engl. 2022 Dec 23;61(52):e202213872. doi: 10.1002/anie.202213872. Epub 2022 Nov 24.
4
Synthesis, X-ray diffraction analysis, quantum chemical studies and -amylase inhibition of probenecid derived -alkylphthalimide-oxadiazole-benzenesulfonamide hybrids.
J Enzyme Inhib Med Chem. 2022 Dec;37(1):1464-1478. doi: 10.1080/14756366.2022.2078969.
5
Anti-gout Medications and Risk of Cardiovascular Disease: A Nested Case-Control Study.
Front Med (Lausanne). 2021 Oct 18;8:739680. doi: 10.3389/fmed.2021.739680. eCollection 2021.
6
Efficacy and safety of urate-lowering therapy in people with kidney impairment: a GCAN-initiated literature review.
Rheumatol Adv Pract. 2021 Jan 4;5(1):rkaa073. doi: 10.1093/rap/rkaa073. eCollection 2021.
7
Association Between Use of Anti-gout Preparations and Dementia: Nested Case-Control Nationwide Population-Based Cohort Study.
Front Med (Lausanne). 2021 Jan 12;7:607808. doi: 10.3389/fmed.2020.607808. eCollection 2020.
8
-Butyrylated hyaluronic acid ameliorates gout and hyperuricemia in animal models.
Pharm Biol. 2019 Dec;57(1):717-728. doi: 10.1080/13880209.2019.1672755.
9
The Treatment of Gout-1967.
J R Coll Physicians Lond. 1967 Jul;1(4):427-441.
10
Probenecid protects against transient focal cerebral ischemic injury by inhibiting HMGB1 release and attenuating AQP4 expression in mice.
Neurochem Res. 2014 Jan;39(1):216-24. doi: 10.1007/s11064-013-1212-z. Epub 2013 Dec 7.
本文引用的文献
1
Production of Acute Gouty Arthritis by Adrenocorticotropin.
Science. 1949 Mar 18;109(2829):280-1. doi: 10.1126/science.109.2829.280.
2
SERUM URATE IN RELATIVES OF GOUTY PATIENTS.
J Clin Invest. 1940 Jul;19(4):645-8. doi: 10.1172/JCI101167.
3
The effect of salicylates and adrenocorticotropic hormone upon the miscible pool of uric acid in gout.
J Clin Invest. 1950 Aug;29(8):1104-11. doi: 10.1172/JCI102343.
4
The influence of a new benzoic acid derivative on the metabolism of paraaminosalicylic acid (PAS) and penicillin.
Ann Intern Med. 1950 Jul;33(1):18-31. doi: 10.7326/0003-4819-33-1-18.
5
The clinical usefulness of ACTH and cortisone.
N Engl J Med. 1950 May 25;242(21):824-34; contd. doi: 10.1056/NEJM195005252422105.
6
The metabolism of uric acid in the normal and gouty human studied with the aid of isotopic uric acid.
J Biol Chem. 1949 Nov;181(1):183-93.
7
Effect of benemid (p-[di-n-propylsulfamyl]-benzoic acid) on urate clearance and other discrete renal functions in gouty subjects.
J Clin Invest. 1952 Jul;31(7):692-701. doi: 10.1172/JCI102651.
8
Mobilization of gouty tophi by protracted use of uricosuric agents.
Am J Med. 1951 Dec;11(6):765-9. doi: 10.1016/0002-9343(51)90028-9.
9
The clinical and metabolic effects of benemid in patients with gout.
Trans Assoc Am Physicians. 1951;64:372-7.
10
A modified technique for determining uric acid in blood and urine.
J Clin Pathol. 1951 Aug;4(3):370-3. doi: 10.1136/jcp.4.3.370.
Zotero 插件